The expression of MMP2 is a prognostic marker for patients with MM that could independently predict patient survival (55), and its expression has been related to the poorer survival of patients with melanoma (55), consistent with varied PCDH9 expression in melanoma cells. The gene discussed is PCDH9; the disease is melanoma.